Corporate Relations

Connecting people with people. Connecting companies with opportunities.
Corp Relations_banner

The IASLC offers several corporate partnership opportunities for our upcoming meetings. In 2022, we look forward to offering in-person meetings with options for virtual engagement. In addition to our meeting and event opportunities, we also offer opportunities for specialized partnerships to support our resources, programs, scientific projects, and more.

Ways to Partner With Iaslc

The IASLC has numerous ways to engage with our corporate partners. Explore the offerings below to learn more about each opportunity. Contact us to discuss your needs and interests, and let us develop a specialized opportunity to bring you and our global audience together.

Contact Us

IASLC 2022 WCLC

Image of Vienna Austria

The IASLC 2022 World Conference on Lung Cancer will be held August 6-9 in Vienna, Austria. There will be multiple opportunities for interaction. 

Learn more

IASLC 2022 NACLC

IASLC 2022 North America Conference on Lung Cancer

Contact us to learn more about the IASLC 2022 North America Conference on Lung Cancer in Chicago, IL, USA from September 23-25, 2022. 

Learn More

IASLC 2022 ACLC

Collage of famous landmarks in Nara Japan

Contact us to learn more about the IASLC 2022 Asia Conference on Lung Cancer in Nara, Japan from October 27-29, 2022. 

Learn More

IASLC 2023 LALCA

Corp Relations_specialized

Learn more about the IASLC 2023 Latin America Conference on Lung Cancer in Montevideo, Uruguay January 25-28, 2023.

Learn More

Advocacy initiatives

Corp Relations_advocacy

Help us engage patients and patient advocates in new and exciting ways.

Learn more

Committee Projects

Corp Relations_committees

Committee projects often involve closer looks at standard of care and how to improve it through discussion, education, and dissemination of data.

Learn More

Research Funding

Join IASLC’s member community

Each year the IASLC supports young researchers in order to reward scientific excellence and to encourage innovative research in lung cancer prevention and translational medicine worldwide.

Learn more

Contact Corporate Relations